SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001493152-22-011543
Filing Date
2022-04-29
Accepted
2022-04-29 16:00:52
Documents
13
Period of Report
2022-04-28
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 form8-k.htm   iXBRL 8-K 40296
2 ex3-1.htm EX-3.1 7344
  Complete submission text file 0001493152-22-011543.txt   224438

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE pulm-20220428.xsd EX-101.SCH 3036
4 XBRL LABEL FILE pulm-20220428_lab.xml EX-101.LAB 34476
5 XBRL PRESENTATION FILE pulm-20220428_pre.xml EX-101.PRE 22597
7 EXTRACTED XBRL INSTANCE DOCUMENT form8-k_htm.xml XML 3716
Mailing Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421
Business Address 99 HAYDEN AVENUE SUITE 390 LEXINGTON MA 02421 (781) 357-2333
Pulmatrix, Inc. (Filer) CIK: 0001574235 (see all company filings)

IRS No.: 461821392 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-36199 | Film No.: 22875021
SIC: 2834 Pharmaceutical Preparations